In this episode we speak to Jason Carroll, the CEO of Tryptamine Therapeutics.

Tryptamine Therapeutics Limited is a clinical-stage biotechnology company focused on bringing transformative medicine with known safety profiles to diseases with no effective first-line treatments.

Jason brings a wealth of experience as a highly regarded life sciences executive, with an impressive 32-year career in the industry. In addition to his most recent role as Managing Director of iNova Pharmaceuticals Philippines, his extensive background includes leadership roles at industry giants Johnson & Johnson, Janssen Pharmaceutica, and Bristol-Myers Squibb.Jason received his B.Sc. in Organic Chemistry from Flinders University of South Australia and completed his Master of Business Admini ...